We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 15

More clarity for complex biosimilars: Europe approved the first follow-on monoclonal antibodies Canada follows suit

  • Bereskin & Parr LLP
  • -
  • Canada, European Union
  • -
  • March 7 2014

Last year, the European Medicines Agency (EMA) granted marketing authorizations to two biosimilar versions of Johnson & Johnson's rheumatoid

Medicinal products : information and advertising

  • CMS DeBacker
  • -
  • European Union
  • -
  • March 4 2014

Five years after the European Court of Justice (the "ECJ") rendered its judgment in the Damgaard case (Case C-42107, judgment of 2 April 2009

Antitrust and competition the EU weekly briefing (21 January 2014)

  • Winston & Strawn LLP
  • -
  • European Union, United Kingdom
  • -
  • January 21 2014

On 13 January 2014, the European Commission (Commission) announced formal proceedings to investigate restrictions concerning the provision of

Prescription medicines: how to differentiate information from advertising in the EU

  • Stibbe
  • -
  • European Union
  • -
  • March 5 2012

The question of how to distinguish between advertising and providing information on prescription medicines has returned to the spotlight, following the European Commission's publication of its revised proposals on information to patients and pharmacovigilance in February

Competition

  • Dentons
  • -
  • European Union, United Kingdom
  • -
  • January 5 2012

The European Commission is pursuing formal antitrust proceedings to investigate whether a number of international publishers have, possibly with the help of Apple, engaged in anti-competitive practices affecting the sale of e-books in the EU

What you need to know about the law relating to the marketing of dietary supplements in the U.S., the EU and China

  • Kelley Drye & Warren LLP
  • -
  • China, European Union, USA
  • -
  • July 22 2011

Consumers around the world are increasing their use of dietary supplements

Food marketing to youth discussed in Brussels

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • April 8 2011

According to public health lawyer and activist Michele Simon, who recently attended a meeting in Brussels "to address the problem of cross-border marketing of unhealthy food to children," the same types of issues confronting public health advocates in the United States confront their counterparts in Europe

EFSA issues additional opinions on “functional food” health claims

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 22 2010

In its ongoing review of food product health claims, the European Food Safety Authority (EFSA) has adopted 75 new opinions addressing 808 claims

Advertising and independent statements

  • Fasken Martineau DuMoulin LLP
  • -
  • Denmark, European Union
  • -
  • October 26 2009

Generally, advertising rules (as set out in Articles 86 to 100 of Directive 200183) as implemented nationally, are aimed at marketing authorisation holders

Prohibition on advertising unregistered medicinal products applies also to independent third parties

  • De Brauw Blackstone Westbroek
  • -
  • Denmark, European Union
  • -
  • July 31 2009

The prohibition on advertising unregistered medicinal products applies not only to pharmaceutical companies but also to independent third parties, including journalists whose right of freedom of expression may be limited for the purpose of protecting public health